申请人:Glick Gary D.
公开号:US20120270862A1
公开(公告)日:2012-10-25
The present invention provides novel chemical compounds characterized as Rho kinase (ROCK) inhibitors, methods for their discovery, and their therapeutic, research, and diagnostic use. In particular, the present invention provides 1,4-benzo-diazepine-2,5-dione compounds and related compounds having ROCK inhibitory activity, and methods of using such compounds as therapeutic agents to treat a number of conditions associated with ROCK activity.
本发明提供了新型化合物,其特征是Rho激酶(ROCK)抑制剂,以及它们的发现方法和它们的治疗、研究和诊断用途。特别是,本发明提供了具有ROCK抑制活性的1,4-苯并二氮平-2,5-二酮化合物和相关化合物,以及使用这些化合物作为治疗剂治疗与ROCK活性相关的多种疾病的方法。